申请人:The Regents of the University of Colorado, a body corporate
公开号:US20150343016A1
公开(公告)日:2015-12-03
The present invention describes the use of translation inhibitors for the treatment of cancer and other disorders. Described herein are translation-inhibiting compounds, and methods of using those compounds for the treatment of cancer and other disorders. In some aspects the compounds inhibit translation elongation at the ribosome. In some aspects the compounds are used alone or in combination with known therapies.
BOURVADIN DERIVATIVES AND THERAPEUTIC USES THEREOF
申请人:SU Tin Tin
公开号:US20150238562A1
公开(公告)日:2015-08-27
The present invention is directed at bouvardin analogs arid related compounds for the treatment of disorders including cancer. Provided herein are bouvardin analogs and related compounds, pharmaceutical compositions and kits comprising at least one bouvardin analog or related compound, and methods for treating disorders including cancer. In some aspects the compounds inhibit translation elongation at the ribosome. The compounds are used in combination with radiation therapy or with known chemotherapeutic compositions.